Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1621 1625 3781
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18686168 | COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA | Non-Final OA | VERADERMICS INCORPORATED |
| 19412192 | HALOBETASOL PROPIONATE-LIDOCAINE FORMULATIONS | Non-Final OA | Citius Pharmaceuticals, Inc. |
| 17801709 | POTENT AND SELECTIVE DEGRADERS OF ALK | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 18041058 | COMPANION DIAGNOSTIC FOR AXITINIB | Non-Final OA | The Regents of The University of Michigan |
| 17416876 | QUINOLINYL-PYRAZINE-CARBOXAMIDE COMPOUNDS AND USES THEREOF | Non-Final OA | The Regents of the University of Michigan |
| 17802872 | COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME | Final Rejection | University of Florida Research Foundation, Incorporated |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy